230 related articles for article (PubMed ID: 1397878)
1. Effect of loxiglumide on basal and gastrin- and bombesin-stimulated gastric acid and serum gastrin levels.
Jebbink MC; Lamers CB; Mooy DM; Rovati LC; Jansen JB
Gastroenterology; 1992 Oct; 103(4):1215-20. PubMed ID: 1397878
[TBL] [Abstract][Full Text] [Related]
2. Effect of the specific cholecystokinin-receptor antagonist loxiglumide on bombesin stimulated pancreatic enzyme secretion in man.
Jebbink MC; Jansen JB; Mooy DM; Rovati LC; Lamers CB
Regul Pept; 1991 Feb; 32(3):361-8. PubMed ID: 1714084
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin in the control of gastric acid secretion in humans.
Konturek JW; Gutwinska-Konturek M; Gabryelewicz A; Konturek SJ; Domschke W
J Clin Gastroenterol; 1993; 17 Suppl 1():S40-5. PubMed ID: 7904286
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin in the control of gastric acid secretion in man.
Konturek JW; Stoll R; Konturek SJ; Domschke W
Gut; 1993 Mar; 34(3):321-8. PubMed ID: 8472978
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion.
Schmidt WE; Creutzfeldt W; Höcker M; Nustede R; Choudhury AR; Schleser A; Rovati LC; Fölsch UR
Eur J Clin Invest; 1991 Oct; 21(5):501-11. PubMed ID: 1752290
[TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
Konturek JW
J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
[TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of gastrin in humans.
Schmidt WE; Schenk S; Nustede R; Holst JJ; Fölsch UR; Creutzfeldt W
Gastroenterology; 1994 Dec; 107(6):1610-20. PubMed ID: 7958670
[TBL] [Abstract][Full Text] [Related]
8. Loxiglumide inhibits cholecystokinin stimulated somatostatin secretion and simultaneously enhances gastric acid secretion in humans.
Verhulst ML; Gielkens HA; Hopman WP; van Schaik A; Tangerman A; Rovati LC; Jansen JB
Regul Pept; 1994 Oct; 53(3):185-93. PubMed ID: 7846294
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin is a physiological regulator of gastric acid secretion in man.
Burckhardt B; Delco F; Ensinck JW; Meier R; Bauerfeind P; Aufderhaar U; Ketterer S; Gyr K; Beglinger C
Eur J Clin Invest; 1994 Jun; 24(6):370-6. PubMed ID: 7957488
[TBL] [Abstract][Full Text] [Related]
10. Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog.
de Jong AJ; Singer MV; Jansen JB; Niebel W; Rovati LC; Lamers CB
Gut; 1991 Feb; 32(2):215-9. PubMed ID: 1864545
[TBL] [Abstract][Full Text] [Related]
11. Effect of duodenal juice on bombesin-stimulated cholecystokinin release during loxiglumide administration in man.
Jebbink MC; Jansen JB; van der Kleij FG; Mooy DM; Rovati LC; Lamers CB
Eur J Clin Invest; 1993 Sep; 23(9):529-33. PubMed ID: 8243522
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin in the control of gastric acid secretion and gastrin release in response to a meal at low and high pH in healthy subjects and duodenal ulcer patients.
Konturek JW; Konturek SJ; Domschke W
Scand J Gastroenterol; 1995 Aug; 30(8):738-44. PubMed ID: 7481540
[TBL] [Abstract][Full Text] [Related]
13. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans.
Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C
J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712
[TBL] [Abstract][Full Text] [Related]
14. Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on postprandial gastrin release in duodenal ulcer patients.
Konturek JW; Gillessen A; Konturek SJ; Domschke W
Gut; 1995 Oct; 37(4):482-7. PubMed ID: 7489932
[TBL] [Abstract][Full Text] [Related]
15. Effect of loxiglumide (CR-1505) on bombesin- and meal-stimulated plasma cholecystokinin in man.
Jansen JB; Jebbink MC; Douglas BR; Lamers CB
Eur J Clin Pharmacol; 1990; 38(4):367-70. PubMed ID: 2344859
[TBL] [Abstract][Full Text] [Related]
16. Cholecystokinin in the inhibition of gastric secretion and gastric emptying in humans.
Konturek SJ; Kwiecien N; Obtulowicz W; Kopp B; Oleksy J; Rovati L
Digestion; 1990; 45(1):1-8. PubMed ID: 2340960
[TBL] [Abstract][Full Text] [Related]
17. Role of endogenous bombesin-peptides during vagal stimulation of gastric acid secretion in the rat.
Weigert N; Li YY; Lippl F; Coy DH; Classen M; Schusdziarra V
Neuropeptides; 1996 Dec; 30(6):521-7. PubMed ID: 9004248
[TBL] [Abstract][Full Text] [Related]
18. Effects of lorglumide on gastrin- and peptone-stimulated gastric acid secretion in rats.
van de Brug FJ; Jansen JB; Kuijpers IJ; Lamers CB
Life Sci; 1990; 47(26):2459-64. PubMed ID: 2263169
[TBL] [Abstract][Full Text] [Related]
19. Eradication of Helicobacter pylori infection in patients with non-ulcer dyspepsia. Effects on basal and bombesin-stimulated serum gastrin and gastric acid secretion.
Verhulst ML; Hopman WP; Tangerman A; Jansen JB
Scand J Gastroenterol; 1995 Oct; 30(10):968-73. PubMed ID: 8545617
[TBL] [Abstract][Full Text] [Related]
20. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
Gabryelewicz A; Kulesza E; Konturek SJ
Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
